Back to Newsroom

Seattle BioMed Researchers Identify Two HIV-1 Envelope Immunogens Capable of Eliciting Antibodies Associated with Vaccine Protection

Seattle, WA., January 24, 2013 — Seattle BioMed researchers identified two HIV-1 Envelope immunogens that elicit broadly neutralizing antibodies when introduced as a vaccine. The study was published online in PLOS One.